A controlled trial of nortriptyline or sustained-release bupropion for smoking cessation Source: Annual Congress 2004 - Issues in tobacco control Year: 2004
Efficacy of bupropion therapy in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004
Behavioural intervention increased efficacy of bupropion in a group of mexican heavy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 125s Year: 2003
Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004
Results of a Bulgarian smoking cessation trial with bupropion hydrochloride 150 mg SR Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001
Randomized clinical trials with nicotine inhaler for smoking cessation Source: Eur Respir J 2003; 22: Suppl. 45, 166s Year: 2003
Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial. Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017
Evaluation of varenicline plus behavioural intervention in a group of Mexican smokers Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008
Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial}, Source: Eur Respir J 2012; 40: 548-554 Year: 2012
A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002
Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001
Experiencing bupropion hydrochloride in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004
Safety and tolerability of indacaterol once-daily in COPD patients versus placebo and tiotropium: a 26-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009
Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 11s Year: 2001
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial Source: ERJ Open Res, 7 (3) 00255-2021; 10.1183/23120541.00255-2021 Year: 2021
Effect of pre-treatment with the nicotine patch on withdrawal symptoms in smokers subsequently quitting with the nicotine patch: a double-blind randomised controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
Efficacy and safety of as-needed corticosteroid plus fast or short-acting beta-agonists monotherapy in patients with mild asthma: a meta-analysis of randomised controlled trials. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial Source: Eur Respir J 2010; 35: 287-294 Year: 2010